Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens

Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens

The introduction of novel drugs (<i>PD-1</i> inhibitors and/or brentuximab vedotin) into salvage regimens has improved the response rate and the outcome of patients with relapsed/refractory Hodgkin lymphoma. However, the impact of new drugs on the outcome has not been adequately investig...

Full description

Bibliographic Details
Main Authors: Jacopo Mariotti, Francesca Ricci, Laura Giordano, Daniela Taurino, Barbara Sarina, Chiara De Philippis, Daniele Mannina, Carmelo Carlo-Stella, Stefania Bramanti, Armando Santoro
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cells
Subjects:
Hodgkin lymphoma
transplantation
new drugs
Online Access:https://www.mdpi.com/2073-4409/13/2/118

Internet

https://www.mdpi.com/2073-4409/13/2/118

Similar Items